Literature DB >> 21866382

Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis.

Walter Ludwig Strohmaier1, Beate Maria Wrobel, Gernot Schubert.   

Abstract

Overweight, arterial hypertension and disturbances of the carbohydrate metabolism are important parameters of the metabolic syndrome (MS). The most important factor regarding renal pathophysiology is insulin resistance resulting in alterations of urine acidification and low urine pH. Since low urine pH is the main risk factor for uric acid urolithiasis (UAU), UAU may be regarded as a renal manifestation of the MS. So far, there are only few data on the prevalence of parameters of the MS in UAU patients especially with regard to the severity of the disease and recurrence rate, respectively. The objective of this study was to know more about the prevalence of different parameters of the MS and their importance for the natural history of this type of renal stone disease using a total number of 167 consecutive patients with pure UA stones. Stone analysis was performed by polarization microscopy and X-ray diffraction. The following parameters were measured: age, sex, systolic and diastolic arterial blood pressure (RRs and RRd), number of stone episodes, diabetes mellitus (DM); serum: creatinine, calcium, sodium, potassium, uric acid, glucose; urine: pH-profiles, citrate, calcium, uric acid, ammonia, urea, and creatinine. The following results were obtained (means ± standard deviations): age 61 ± 13 years, BMI 30 ± 6 kg/m(2), BP 147/84 ± 22/13 mmHg, number of stone episodes 1.8 ± 1.2, DM 32%; serum: creatinine 1.3 ± 0.6 mg/dl, glucose 136 ± 52 mg/dl, UA 6.3 ± 1.8 mg/dl, calcium 2.4 ± 1.3 mmol/l, sodium 134 ± 18 mmol/l, potassium 4.1 ± 0.4 mmol/l; urine: pH 5.87 ± 0.27, volume 2.4 ± 1.1 l/d, calcium 3.5 ± 2.5 mmol/d, UA 3.9 ± 2.4 mmol/d, citrate 1.3 ± 1.1 mmol/d, ammonia 41 ± 26 mmol/d, urea 390 ± 176 mmol/d. A significant positive correlation could be found for BMI and urea excretion, BMI correlated negatively with RRs and RRd. There was no significant correlation between BMI, urine pH, citrate, ammonia and UA in serum and urine. Undue acidity and hyperuricosuria were found in two-thirds of the UAU patients, increased urea excretion and decreased excretion of ammonia in less than 25%, Hyperuricemia in 37%. There was no significant correlation between the number of stone episodes and any other parameter studied. Overweight, arterial hypertension and DM as parameters of the MS are frequent in many patients with UAU. However, these parameters do explain the pathogenesis in two-thirds of the patients. The severity of the disease and the recurrence are not influenced by the presence of these metabolic parameters. Therefore, MS is no prognostic factor in UAU.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866382     DOI: 10.1007/s00240-011-0403-9

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  22 in total

Review 1.  Renal mechanisms for regulation of uric acid excretion, with special reference to normal and gouty man.

Authors:  A B Gutman; T F Yü
Journal:  Semin Arthritis Rheum       Date:  1972       Impact factor: 5.532

2.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

3.  Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population.

Authors:  Ryosuke Ando; Sadao Suzuki; Teruo Nagaya; Tamaki Yamada; Atsushi Okada; Takahiro Yasui; Keiichi Tozawa; Shinkan Tokudome; Kenjiro Kohri
Journal:  Int J Urol       Date:  2010-12-22       Impact factor: 3.369

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence.

Authors:  Jelena Klisic; Ming Chang Hu; Vera Nief; Livia Reyes; Daniel Fuster; Orson W Moe; Patrice M Ambühl
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

6.  Association of urinary pH with body weight in nephrolithiasis.

Authors:  Naim M Maalouf; Khashayar Sakhaee; Joan H Parks; Frederic L Coe; Beverley Adams-Huet; Charles Y C Pak
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity.

Authors:  Domenico Rendina; Giuseppe Mossetti; Gianpaolo De Filippo; Domenico Benvenuto; Carmen Liliana Vivona; Alessia Imbroinise; Giorgia Zampa; Salvatore Ricchio; Pasquale Strazzullo
Journal:  Nephrol Dial Transplant       Date:  2008-10-03       Impact factor: 5.992

8.  Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.

Authors:  S Takahashi; T Inokuchi; T Kobayashi; T Ka; Z Tsutsumi; Y Moriwaki; T Yamamoto
Journal:  Horm Metab Res       Date:  2007-07       Impact factor: 2.936

9.  Hormonal regulation of glutamine metabolism by OK cells.

Authors:  I Nissim; B States; I Nissim; Z P Lin; M Yudkoff
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

Review 10.  Is the worldwide epidemic of obesity a communicable feature of globalization?

Authors:  S R Bornstein; M Ehrhart-Bornstein; M L Wong; J Licinio
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-09-05       Impact factor: 2.949

View more
  14 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.

Authors:  Leonardo Spatola; Claudio Angelini; Salvatore Badalamenti; Silvio Maringhini; Giovanni Gambaro
Journal:  Urolithiasis       Date:  2016-12-05       Impact factor: 3.436

3.  Is urolithiasis associated with increased levels of high sensitivity C-reactive protein and interleukin-6 in diabetic patients?

Authors:  Aysha Hasna; Kavitha Meiyappan; Senthilkumar Gandhipuram Periyasam; Muruganandham Kalyaperumal; Zachariah Bobby; Arul Vijaya Vani Subramaniam
Journal:  J Clin Diagn Res       Date:  2015-03-01

4.  The impacts of metabolic syndrome on the risk of severe urolithiasis.

Authors:  Qingsong Fu; Linguo Xie; Chengwen Diao; Xierzhati Aizezi; Xiaoyu Liu; Chunyu Liu
Journal:  Urolithiasis       Date:  2022-05-09       Impact factor: 2.861

5.  Kidney stone composition in overweight and obese patients: a preliminary report.

Authors:  Hisham A Mosli; Hala H Mosli; Wissam K Kamal
Journal:  Res Rep Urol       Date:  2013-01-10

Review 6.  The association of metabolic syndrome and urolithiasis.

Authors:  Yee V Wong; Paul Cook; Bhaskar K Somani
Journal:  Int J Endocrinol       Date:  2015-03-22       Impact factor: 3.257

7.  Association between chronic pancreatitis and urolithiasis: A population-based cohort study.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Long-Bin Jeng
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

8.  Correlation of metabolic syndrome and urolithiasis: A prospective cross-sectional study.

Authors:  Keerthi Rams; S Joseph Philipraj; Rohit Purwar; Balabhaskar Reddy
Journal:  Urol Ann       Date:  2020-04-14

Review 9.  Confounding risk factors and preventative measures driving nephrolithiasis global makeup.

Authors:  Samuel Shin; Aneil Srivastava; Nazira A Alli; Bidhan C Bandyopadhyay
Journal:  World J Nephrol       Date:  2018-11-24

10.  Nomogram to predict uric acid kidney stones based on patient's age, BMI and 24-hour urine profiles: A multicentre validation.

Authors:  Fabio Cesar Miranda Torricelli; Robert Brown; Fernanda C G Berto; Sarah Tarplin; Miguel Srougi; Eduardo Mazzucchi; Manoj Monga
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.